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Abstract
The use of boron neutron capture therapy (BNCT) for the treatment of deep-seated tumors requires neutron beams
of suitable energy and intensity. Simulations indicate the optimal energy to reside in the epithermal region, in particular
between 1 and 10 keV. Therapeutic neutron beams with high spectral purity in this energy range could be produced with
accelerator-based neutron sources through a suitable neutron-producing reaction. Herein, we report on diﬀerent
solutions that have been investigated as possible sources of epithermal neutron beams for BNCT. The potential use of
such sources for a hospital-based therapeutic facility is discussed. r 2002 Elsevier Science B.V. All rights reserved.
1. Introduction
BNCT is a two-component therapeutic modality
currently considered for the treatment of a number
of malignant tumors resistant to other chemo- and
radiotherapeutic methods. In particular, this kind
of hadrontherapy could reveal useful in the
treatment of Glioblastoma Multiforme (GBM),
an aggressive type of brain cancer [1]. The method
is based on the radiation damage produced by high
LET particles emitted in the 10B neutron capture
reaction 10B(n,a)7Li. To obtain a high tumor
control probability with minimal collateral eﬀects
on healthy tissues, an adequate concentration of
10B has to selectively accumulate in the tumor cells
by means of speciﬁc borated compounds. The
patient is then irradiated with neutron beams of
energy and intensity suitably chosen so that a
maximum density of thermal neutrons is reached
in the proximity of the tumor area.
Clinical BNCT trials are currently undergoing
at nuclear reactors; however, the development of
high intensity accelerators could lead to high-
quality, safe, and cost-eﬀective epithermal neutron
sources for BNCT (see for example Ref. [2]). In
fact, compared to nuclear reactors, accelerator-
based sources may allow to produce epithermal
neutron beams with higher spectral purity and
lower contamination of g-rays, and the use of low-
energy accelerators may enable the operation of
BNCT facilities in metropolitan areas.
We report on a study of diﬀerent neutron
producing reactions that could be used in con-
junction with high-current accelerators, to produce
epithermal neutron beams for BNCT. The main
features of the reactions and the requirements of
the primary particle beam are presented and
discussed, in particular, regarding the potential
use of such sources in hospital-based BNCT
facilities.
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2. Optimal energy of therapeutic neutrons
The optimal energy of a neutron beam for the
treatment of deep-seated tumors can be investi-
gated by means of simulations of the dose
deposition in tissues. To this end, we have used
the GEANT/Micap package [3]. A realistic de-
scription of the geometry and of the head
composition was used, with a tumor region located
at 5 cm depth inside the brain. In the simulations,
10B was speciﬁcally included in normal and tumor
tissues, in concentrations of 10 and 43 parts-per-
million respectively. These loading are typical of
BPA, a 10B-carrier currently used in clinical trials.
RBE values of 1.6 and 2.3 were chosen for protons
and a-particles, respectively.
The quality of the neutron beam was assessed by
analyzing several ﬁgures of merit of the simulated
dose distribution, as a function of the neutron
energy. Fig. 1a shows the therapeutic gain (TG),
deﬁned as the ratio between the dose released to
the tumor and the maximum dose to normal
tissues, for a tumor depth of 5 (solid symbols) and
8 cm (open symbols). One observes that the
optimal neutron energy for the considered tumor
location and 10B concentration is between 1 and
10 keV. Neutrons of lower energy thermalize at
depths smaller than the tumor location, while for
higher energies, recoiling protons lead to a sharp
increase of the dose released to the normal tissues,
in particular, to the skin and at the brain surface.
The depth-dose proﬁle in brain is shown in Fig. 1b
for a 4 keV neutron beam.
Although monoenergetic neutron beams with
energies of 1–10 keV cannot be readily produced,
one should try to approach such a condition in
order to optimize the therapeutic eﬀect. In the case
of reactor-based sources, the energy distribution of
the neutron beam can be optimized by an
appropriate choice of the material and geometry
of the beam shaping assembly. A large improve-
ment in the quality of the epithermal neutron
beam could be achieved by using an accelerator
and a suitable proton- or deuteron-induced reac-
tion for neutron production. The choice of the
beam energy and of the target is mainly dictated
by the need of a high yield of low-energy neutrons
(Eno1MeV), and a small contamination of high-
energy neutron and g-rays. Furthermore, the size
and cost of the accelerator could be minimized by
choosing a low energy for the primary beam, while
the target should present good mechanical and
thermal properties. Finally, a stable residue should
be produced in the reaction, to reduce safety
problems associated with storage and disposal of
the targets.
Several approaches can be used in the choice of
the primary beam energy and conversion target.
Various proposed solutions rely on the use of the
7Li(p,n)7Be reaction at energy EpB2:5MeV or on
the 7Be(p,n)7B reaction at Ep > 3MeV [4,5]). For
these reactions, the proton beam current needed to
Fig. 1. (a) Ratio between the BNCT dose released to tumor and
the maximum dose to normal tissues as a function of neutron
energy. (b) Depth-dose distribution in the brain for a neutron
beam of 4 keV energy. The symbols represent the total dose,
while the dashed curves depict the partial doses produced by the
various reactions occurring in biological tissues (n–p elastic
scattering, the 1H(n,g)2H, the 14N(n,p)14C and the 10B(n,a)7Li
capture reactions).
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produce neutron ﬂuences adequate for the therapy
ranges from 1–30mA, depending on the required
quality of the therapeutic neutron beam. The use
of the Li(p,n) reaction, however, is complicated by
the low melting point of the target (1701) and by
the production of the radioactive 7Be residue. On
the other hand, the Be target is useful only at a
relatively higher proton energy. For this reason,
alternative approaches for the production of
epithermal neutrons are being investigated.
3. Neutron-producing reactions at low energy
A promising approach is represented by (d; n)
reactions at low energy. Most of these reactions
present a positive Q-value, which in principle
allows for the use of deuteron beams of energy as
low as 1MeV. To investigate the feasibility of this
latter approach, we have performed a systematic
study of the yield, energy and angular distribution
of neutrons emitted in low-energy (d;n) reactions
[6]. The measurements were performed at the 8800
Cyclotron of Lawrence Berkeley National Labora-
tory, USA, in collaboration with groups from the
Nuclear Science and Life Science Divisions of
LBNL. The setup used in the measurements
consisted of ﬁve liquid scintillator cells, with n=g
discrimination properties and a minimum thresh-
old of 100 keV on the neutron energy, recon-
structed by time-of-ﬂight relative to the cyclotron
RF. Among the diﬀerent targets investigated at
deuteron energies Edo2MeV, only 9Be and 13C
present a yield suﬃciently high to be of interest for
the production of epithermal neutrons for BNCT,
with the Be target producing neutrons almost a
factor of 2 greater than that produced by 13C.
Fig. 2 shows the energy distribution and TOF
spectrum for both targets. Due to the large
contamination of high energy neutrons, the
9Be(d,n) reaction does not produce epithermal
neutrons with the intensity and spectral character-
istics adequate for BNCT. On the contrary, the
relatively large-yield and low-contamination of
high-energy neutrons make the 13C(d,n)14N reac-
tion at Ed ¼ 1:5MeV potentially interesting for a
hospital-based facility, thanks also to the good
thermal and mechanical properties of the C target
and the low-energy of the primary beam, which
would result in a relatively simple and inexpensive
accelerator. The solid histogram in Fig. 3 repre-
sents the spectrum of epithermal neutrons that
would be produced by the 13C(d,n)14N reaction
with a moderator of LiF 25 cm thick, a reﬂector of
Al2O3, a delimiter of lithiated polyethilene and an
6Li layer for thermal neutron ﬁltering. The current
required for a treatment time of 15min was
estimated for this reaction to be around 100mA,
a value within reach of the high-intensity accel-
erator technology currently being developed.
Finally, a class of suitable neutron sources is
represented by the near-threshold reactions. In this
case, the low-yield of neutrons is compensated by
Fig. 2. Eﬃciency-corrected energy spectrum and time-of-ﬂight
distributions (inside panel) of neutron emitted in the
13C(d,n)14N (panel a) and 9Be(d,n)10B reactions (panel b), at
an incident energy of 1.5MeV. The threshold on the light
output of the scintillator cells was kept to 10 keV electron-
equivalent, corresponding to a neutron energy threshold of
100 keV.
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their low-energy permitting moderation for clinical
application. The dashed histogram in Fig. 3 shows
the epithermal neutron spectrum that can be
produced with the 7Li(p,n) reaction at 1.95MeV,
and with a beam shaping assembly comprised of
8 cm thick BeO and a Pb reﬂector. The use of this
reaction requires an estimated proton beam
current of 5mA. Such an intense beam could
become feasible with commercial accelerators or
with the high-current RFQs like the one presently
being developed at the INFN Laboratori Nazio-
nali Legnaro within the TRASCO project.
In conclusion, among the diﬀerent reactions
studied, the 13C(d,n) and the near-threshold
Li(p,n) reactions represent, in our opinion, the
most interesting solutions for a hospital-based
BNCT facility. This is due in part to the relatively
low-cost and small-size of the accelerator. Before
high-intensity accelerators become available, how-
ever, higher-energy reactions might more conve-
niently be used in conjunction with the presently
available research accelerators, to produce neutron
beams for in vitro or animal studies on BNCT.
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Fig. 3. Epithermal neutron energy spectra produced with the
13C(d,n)14N and the near-threshold 7Li(p,n)7Be reactions. The
optimal beam shaping assembly used for each reaction is
indicated.
E. Bisceglie et al. / Nuclear Instruments and Methods in Physics Research A 476 (2002) 123–126126
